# Uniskin (Shanghai) Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/uniskin-shanghai-biotechnology

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.inertiabiotech.com
- Total disclosed funding: $31M
- Latest round: Series B (Dec 1, 2021)
- Investors on record: 4

## About

Based in Shanghai, China and established in 2016, Tricision Biotherapeutics Inc is a technology company that provides biotechnology technology focusing on skin health and big data.

The company builds the skin multi-omics database UNI-HUB through data collection and provides a platform for the industrialization of skin data. At the same time, the company founded the skin care brand UNISKIN to provide consumers with personalized skin care services based on biological data.

## Funding rounds

- Series B, Dec 1, 2021, $16M — MSA Capital, VMS Asset Management
- Series A, May 31, 2021, $16M — Hong Shan, Hony Capital
- Angel, Aug 20, 2020 — Hong Shan

## Investors

- Hong Shan — Angel, Series A
- Hony Capital (https://capitalatlas.ai/funds/hony-capital) — Series A
- MSA Capital (https://capitalatlas.ai/funds/msa-capital) — Series B
- VMS Asset Management (https://capitalatlas.ai/funds/vms-asset-management) — Series B